# Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in Young Adult Women

> **NCT00337818** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 770 (actual)

## Conditions studied

- Papillomavirus Type 16/18 Infection
- Cervical Intraepithelial Neoplasia

## Interventions

- **BIOLOGICAL:** Cervarix™

## Key facts

- **NCT ID:** NCT00337818
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2006-06
- **Final completion:** 2009-01
- **Target enrollment:** 770 (ACTUAL)
- **Last updated:** 2017-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00337818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00337818, "Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in Young Adult Women". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00337818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*